RS Crausman, CA Jennings, RM Tuder, LM Ackerson, CG Irvin and TE King Jr
Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206, USA.

Pulmonary histiocytosis X (PHX) is a diffuse, smoking-related lung disease characterized pathologically by bronchocentric inflammation, cyst formation, and widespread vascular abnormalities and physiologically by exercise limitation. The major mechanism underlying exercise impairment in this disease has not been previously defined. Spirometry, lung volumes, lung mechanics, and exercise physiology were performed on 23 patients with PHX. Two subgroups were identified on the basis of elastic recoil: 12 subjects had an elevated coefficient of elastic recoil with 11 demonstrating a predominant pattern of restriction, and 10 subjects had normal elastic recoil and relatively normal lung function. Exercise performance was severely limited in both subgroups (workload 53 +/- 3%). Abnormalities of ventilatory function and gas exchange were present but did not appear to be exercise- limiting in the majority of subjects. Indices reflecting pulmonary vascular function (DLCO, baseline VD/VT, exercise VD/VT) were abnormal. Strong correlations between overall exercise performance (% predicted VO2max) and indices of vascular involvement were present: DLCO (r = 0.68, p = 0.0004), baseline VD/VT (-0.65, 0.001), exercise VD/VT (- 0.67, 0.0004). Similar correlations were found when exercise performance was measured by maximal workload achieved. We conclude that (1) subjects with PHX present with either normal or predominantly restrictive pulmonary physiology and that (2) exercise impairment is common and appears to reflect pulmonary vascular dysfunction.

This article has been cited by other articles:

				A. Tazi Adult pulmonary Langerhans' cell histiocytosis. Eur. Respir. J., June 1, 2006; 27(6): 1272 - 1285. [Abstract] [Full Text] [PDF]

				A. Caminati and S. Harari Smoking-related Interstitial Pneumonias and Pulmonary Langerhans Cell Histiocytosis. Proceedings of the ATS, January 1, 2006; 3(4): 299 - 306. [Abstract] [Full Text] [PDF]

				G. Simonneau, N. Galie, L. J. Rubin, D. Langleben, W. Seeger, G. Domenighetti, S. Gibbs, D. Lebrec, R. Speich, M. Beghetti, et al. Clinical classification of pulmonary hypertension J. Am. Coll. Cardiol., June 16, 2004; 43(12_Suppl_S): 5S - 12S. [Abstract] [Full Text] [PDF]

				G. F. Abbott, M. L. Rosado-de-Christenson, T. J. Franks, A. A. Frazier, and J. R. Galvin From the Archives of the AFIP: Pulmonary Langerhans Cell Histiocytosis RadioGraphics, May 1, 2004; 24(3): 821 - 841. [Abstract] [Full Text] [PDF]

				J. L. Mendez, H. F. Nadrous, R. Vassallo, P. A. Decker, and J. H. Ryu Pneumothorax in Pulmonary Langerhans Cell Histiocytosis Chest, March 1, 2004; 125(3): 1028 - 1032. [Abstract] [Full Text] [PDF]

				G. Paciocco, E. Uslenghi, A. Bianchi, G. Mazzarella, G. C. Roviaro, G. Vecchi, and S. Harari Diffuse Cystic Lung Diseases: Correlation Between Radiologic and Functional Status Chest, January 1, 2004; 125(1): 135 - 142. [Abstract] [Full Text] [PDF]

				K. M. Sundar, M. V. Gosselin, H. L. Chung, and B. C. Cahill Pulmonary Langerhans Cell Histiocytosis: Emerging Concepts in Pathobiology, Radiology, and Clinical Evolution of Disease Chest, May 1, 2003; 123(5): 1673 - 1683. [Abstract] [Full Text] [PDF]

				J.H. Ryu, T.V. Colby, T.E. Hartman, and R. Vassallo Smoking-related interstitial lung diseases: a concise review Eur. Respir. J., January 1, 2001; 17(1): 122 - 132. [Abstract] [Full Text] [PDF]

				R. Vassallo, J. H. Ryu, T. V. Colby, T. Hartman, and A. H. Limper Pulmonary Langerhans'-Cell Histiocytosis N. Engl. J. Med., June 29, 2000; 342(26): 1969 - 1978. [Full Text] [PDF]

				A. Tazi, P. Soler, and A. J Hance Rare diseases bullet 9: Adult pulmonary Langerhans' cell histiocytosis Thorax, May 1, 2000; 55(5): 405 - 416. [Full Text]

				T. King Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment . International Consensus Statement Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 646 - 664. [Full Text]

				M. FARTOUKH, M. HUMBERT, F. CAPRON, S. MAÎTRE, F. PARENT, C. LE GALL, O. SITBON, P. HERVÉ, P. DUROUX, and G. SIMONNEAU Severe Pulmonary Hypertension in Histiocytosis X Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 216 - 223. [Abstract] [Full Text]

				D. M Mitchell and A. Woodcock Introduction Thorax, August 1, 1999; 54(90002): S1 - 1. [PDF]

				D. V Parums Commentary: "Histiocytosis X" Thorax, April 1, 1998; 53(4): 322 - 323. [Full Text]

				B. T. SOCIETY and S. O. C. COMMITTEE The Diagnosis, Assessment and Treatment of Diffuse Parenchymal Lung Disease in Adults---British Thoracic Society recommendations Thorax, April 1, 1990; 54(90001): 1S - 28. [Full Text]